サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547303

PEG化の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global PEGylation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
PEG化の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

PEG化市場の世界需要は、調査期間2024～2032年のCAGR12.36%で、2023年の20億3,000万米ドルから2032年には約58億米ドルの市場規模に達すると推定されます。

PEG化とは、ポリエチレングリコール（PEG、薬学ではマクロゴールとも呼ばれる）ポリマー鎖を、薬剤、治療用タンパク質、小胞などの分子やマクロ構造に、共有結合と非共有結合の両方で結合または融合させるプロセスです。PEG化は一般に、標的分子を反応性PEG誘導体とインキュベートすることによって達成されます。薬剤や治療用タンパク質へのPEGの共有結合は、宿主の免疫系から薬剤を「隠す」（免疫原性と抗原性を低下させる）ことができ、流体力学的サイズ（溶液中のサイズ）を向上させることができます。疎水性の医薬品やタンパク質をPEG化して水溶性にすることもできます。

市場力学

製薬・バイオ医薬品企業による研究開発投資の増加、生物製剤産業の拡大、生活習慣病の流行、タンパク質の安定性と循環半減期を改善することへの注目と意識の高まりが、市場成長の原動力になると予測されます。さらに、慢性疾患感染者の増加に伴い、様々な慢性疾患の治療にPEG化タンパク質が使用されるようになり、PEG化市場が活性化されると考えられます。PEG化分子は、半減期の延長、毒性の低下、免疫原性の低下、タンパク質分解防御の強化など多くの利点を提供し、これらすべてが市場の継続的拡大に寄与しています。しかしその反面、PEG化プロセスのコスト上昇や特定の医薬品の特許切れなどが市場の成長を阻害すると予想されています。

調査レポートでは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはPEG化の世界市場における各セグメントを包括的に評価することもできます。PEG化産業の成長と動向は、この研究に全体的なアプローチを記載しています。

市場セグメンテーション

PEG化市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会で、それぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるPEG化市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 PEG化-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 PEG化の世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 製品・サービス別過去・予測データ分析
  • 消耗品
  • サービス別

第6章 PEG化の世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去・予測データ分析
  • コロニー刺激因子
  • インターフェロン
  • エリスロポエチン
  • 遺伝子組換え第VII因子
  • その他

第7章 PEG化の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • がん
  • 自己免疫疾患
  • 肝炎
  • 多発性硬化症
  • 血友病
  • 消化器疾患
  • その他

第8章 PEG化の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 製薬・バイオテクノロジー企業
  • 受託研究機関
  • 学術・研究機関
  • PEG化タンパク質

第9章 PEG化の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 PEG化企業の競合情勢

  • PEG化市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Abcam Plc
  • Enzon Pharmaceuticals Inc.
  • Merck KGaA
  • Celares GmbH
  • Profacgen
  • Creative PEGworks
  • NOF America Corp.
  • Aurigene Pharmaceutical Services Ltd.
  • Laysan Bio Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product & Services (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Type (USD MN)
  • Colony-stimulating Factor Market Sales By Geography (USD MN)
  • Interferons Market Sales By Geography (USD MN)
  • Erythropoietin Market Sales By Geography (USD MN)
  • Recombinant Factor VII Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Autoimmune Diseases Market Sales By Geography (USD MN)
  • Hepatitis Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Hemophilia Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • PEGylated Proteins Market Sales By Geography (USD MN)
  • Global PEGylation Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of PEGylation Report
  • Market Research Process
  • Market Research Methodology
  • Global PEGylation Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product & Services
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product & Services (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Type (USD MN)
  • Colony-stimulating Factor Market Sales By Geography (USD MN)
  • Interferons Market Sales By Geography (USD MN)
  • Erythropoietin Market Sales By Geography (USD MN)
  • Recombinant Factor VII Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Autoimmune Diseases Market Sales By Geography (USD MN)
  • Hepatitis Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Hemophilia Market Sales By Geography (USD MN)
  • Gastrointestinal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • PEGylated Proteins Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11216591

The global demand for PEGylation Market is presumed to reach the market size of nearly USD 5.8 Billion by 2032 from USD 2.03 Billion in 2023 with a CAGR of 12.36% under the study period 2024-2032.

PEGylation (or pegylation) is the process of attaching or amalgamating polyethylene glycol (PEG, also known as macrogol in pharmacy) polymer chains to molecules and macrostructures, such as medication, therapeutic protein, or vesicle, in both covalent and non-covalent ways. PEGylation is commonly accomplished by incubating the target molecule with a reactive PEG derivative. The covalent attachment of PEG to a medication or therapeutic protein can ''''hide'''' the agent from the host's immune system (reduce immunogenicity and antigenicity) and enhance its hydrodynamic size (size in solution), which extends its circulation duration by reducing renal clearance. Hydrophobic medicines and proteins can also be PEGylated to make them water-soluble.

MARKET DYNAMICS

Increased R&D investments by pharmaceutical and biopharmaceutical companies, expansion in the biologics industry, rising prevalence of lifestyle illness, and increased attention and awareness on improving protein stability and circulation half-life are projected to drive market growth. Furthermore, as the number of people infected with chronic diseases rise, the PEGylation market will be fueled by the increased usage of PEGylated protein to treat various chronic diseases. PEGylated molecules provide many advantages, including a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all contribute to the market's continued expansion. But on the other side, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of PEGylation. The growth and trends of PEGylation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the PEGylation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

  • Consumables
  • Services

By Type

  • Colony-stimulating Factor
  • Interferons
  • Erythropoietin
  • Recombinant Factor VII
  • Others

By Application

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes
  • PEGylated Proteins

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the PEGylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the PEGylation market include Thermo Fisher Scientific Inc., Abcam Plc, Enzon Pharmaceuticals Inc., Merck KGaA, Celares GmbH, Profacgen, Creative PEGworks, NOF America Corp., Aurigene Pharmaceutical Services Ltd., Laysan Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PEGYLATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEGYLATION MARKET ANALYSIS BY PRODUCT & SERVICES

  • 5.1. Overview By Product & Services
  • 5.2. Historical and Forecast Data Analysis By Product & Services
  • 5.3. Consumables Historic and Forecast Sales By Regions
  • 5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL PEGYLATION MARKET ANALYSIS BY TYPE

  • 6.1. Overview By Type
  • 6.2. Historical and Forecast Data Analysis By Type
  • 6.3. Colony-stimulating Factor Historic and Forecast Sales By Regions
  • 6.4. Interferons Historic and Forecast Sales By Regions
  • 6.5. Erythropoietin Historic and Forecast Sales By Regions
  • 6.6. Recombinant Factor VII Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PEGYLATION MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Cancer Historic and Forecast Sales By Regions
  • 7.4. Autoimmune Diseases Historic and Forecast Sales By Regions
  • 7.5. Hepatitis Historic and Forecast Sales By Regions
  • 7.6. Multiple Sclerosis Historic and Forecast Sales By Regions
  • 7.7. Hemophilia Historic and Forecast Sales By Regions
  • 7.8. Gastrointestinal Disorders Historic and Forecast Sales By Regions
  • 7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL PEGYLATION MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.4. Contract Research Organizations Historic and Forecast Sales By Regions
  • 8.5. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 8.6. PEGylated Proteins Historic and Forecast Sales By Regions

9. GLOBAL PEGYLATION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEGYLATION COMPANIES

  • 10.1. PEGylation Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PEGYLATION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Abcam Plc
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Enzon Pharmaceuticals Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Merck KGaA
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Celares GmbH
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Profacgen
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Creative PEGworks
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. NOF America Corp.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Aurigene Pharmaceutical Services Ltd.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Laysan Bio Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies